Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Comment by biorunon Apr 16, 2024 10:31am
90 Views
Post# 35991432

RE:RE:Biorun..You are truly inspiring

RE:RE:Biorun..You are truly inspiringSmall day trades are meaningless here. 

I would say we have been here time and time again and 100% of the time the stock doubled, tripped, quadrupled etc from these lows.

As I said, it all boils down to whether or not they work through their files and draw in the equity interest they need - the plan is to focus on the Sirona Laboratories launch. 

All I can say is the moment they announce an equity interest with some upfront cash infusion, the stock will 1st fly to reflect the current uncertainty around finances that is pressing on the stock right now by small potatoes, but then a second element to reflect the plan itself and then a third bump to reflect the launch with AbbVie.

It all depends if one believes they have the cash to continue on to meet those milestones. I personally believe they have a reasonable shot, but hey, you never know and that is what these small hands are reacting to. 

Do you see the big players dumping? NO. I don't know what specific relationship Howard has with this niche set of Sirona investors with BIG share positions (i.e. over 3-4 million plus shares), but if they were acting then we would know it.

Let's revisit this moment in the future if things turn as needed for the positive.


<< Previous
Bullboard Posts
Next >>